Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola.
Lucky S MulwaRolf JansenKathrin I MohrJoachim WinkEike SteinmannMarc StadlerPublished in: Molecules (Basel, Switzerland) (2018)
Two new secondary metabolites, labindole A [2-methyl-3-(2-nitroethyl)-3H-indole] (1) and labindole B [2-methyl-3-(2-nitrovinyl)-3H-indole] (2), were isolated from the myxobacterium Labilithrixluteola (DSM 27648T). Additionally, four metabolites 3, 4, 5 and 6 already known from other sources were obtained. Their structures were elucidated from high resolution electrospray ionisation mass spectrometry (HRESIMS) and 1D and 2D nuclear magnetic resonance (NMR) spectroscopy data and their relative configuration was assigned based on nuclear Overhauser effect (NOE) and vicinal ¹H-NMR coupling data. The compounds where tested for biological activities; labindoles A (1) and B (2) exhibited significant activity against Hepatitis C Virus, 9H-carbazole (3), 3-chloro-9H-carbazole (4) and 4-hydroxymethyl-quinoline (5) showed antifungal activities. Moreover, compound 3 had weak to moderate antibacterial activities, while labindoles A (1) and B (2) were devoid of significant antifungal and antibacterial effects.
Keyphrases
- high resolution
- mass spectrometry
- magnetic resonance
- hepatitis c virus
- ms ms
- liquid chromatography
- candida albicans
- electronic health record
- high performance liquid chromatography
- human immunodeficiency virus
- big data
- silver nanoparticles
- gas chromatography
- high intensity
- capillary electrophoresis
- drinking water
- tandem mass spectrometry
- data analysis
- anti inflammatory
- molecular docking
- computed tomography
- magnetic resonance imaging
- electron transfer